Pharma times RSS Feed

A subcutaneous formulation will now be available to treat relapsing-remitting multiple sclerosis

The combination is not considered to be a cost-effective use of NHS resources in this setting

The drug was discovered through an AI-design platform within just eight months of project initiation

The drug failed to significantly reduce progression to ventilation or death in patients hospitalised with COVID-19

The Cancer Research UK spinout is developing precision T cell therapies to treat multiple cancers

Kesimpta is the first self-administered B-cell therapy for patients with relapsing forms of multiple sclerosis

The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine

Data suggest infections in England fell by 60% from February, but the decline is levelling

Supplies of Estradot TTS-75 are expected to return to normal within eight weeks

The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births

The deal could be worth as much as $1.3 billion to Artios

The £20 million fund will boost the UK's life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs

The vaccine is the third to be approved for use in the UK to protect against COVID-19

The 2021 Communications Awards have opened their doors for entry, inviting the very best in pharma communications to come forward and claim first prize.

Funding backed for reversal of gastrointestinal bleeds but not for intracranial haemorrhage

The drug offers new hope for epilepsy patients with focal-onset seizures

The parties intend to develop more cost-effective ways of producing biologic medicines

NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time

Everyone in England, including those without symptoms, will be able to take a free rapid coronavirus test twice a week

Celebrating and uncovering exceptional pharma marketing talent for nearly three decades, the Marketer of the Year competition has launched for 2021.